BEBETTER MED INC. — Investor Relations & Filings
About BEBETTER MED INC.
BEBETTER MED INC. is a clinical-stage company dedicated to the discovery and development of innovative small molecule therapeutics. The organization focuses on addressing unmet medical needs within the fields of oncology, metabolic disorders, and autoimmune diseases. Its research and development pipeline features a range of proprietary drug candidates, with a particular emphasis on targeted therapies and kinase inhibitors. By leveraging advanced drug discovery platforms, the company identifies and optimizes lead compounds to advance through clinical evaluation. BEBETTER MED INC. oversees the entire development lifecycle, including preclinical research, clinical trial management, and the pursuit of regulatory approvals for its therapeutic candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 广州必贝特医药股份有限公司章程 | 2025-11-12 | Chinese | |
| 第二届监事会第七次（临时）会议决议公告 | 2025-11-12 | Chinese | |
| 广州必贝特医药股份有限公司累积投票制度 | 2025-11-12 | Chinese | |
| 广州必贝特医药股份有限公司董事及高级管理人员行为规范 | 2025-11-12 | Chinese | |
| 广州必贝特医药股份有限公司独立董事工作制度 | 2025-11-12 | Chinese | |
| 关于使用部分暂时闲置募集资金进行现金管理的公告 | 2025-11-12 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39585428 | 广州必贝特医药股份有限公司章程 | 2025-11-12 | Chinese | ||
| 39585421 | 第二届监事会第七次（临时）会议决议公告 | 2025-11-12 | Chinese | ||
| 39585411 | 广州必贝特医药股份有限公司累积投票制度 | 2025-11-12 | Chinese | ||
| 39585406 | 广州必贝特医药股份有限公司董事及高级管理人员行为规范 | 2025-11-12 | Chinese | ||
| 39585402 | 广州必贝特医药股份有限公司独立董事工作制度 | 2025-11-12 | Chinese | ||
| 39585394 | 关于使用部分暂时闲置募集资金进行现金管理的公告 | 2025-11-12 | Chinese | ||
| 39585387 | 关于调整募集资金投资项目拟投入募集资金金额的公告 | 2025-11-12 | Chinese | ||
| 39585383 | 关于使用自有资金支付募投项目所需资金并以募集资金等额置换的公告 | 2025-11-12 | Chinese | ||
| 39585375 | 广州必贝特医药股份有限公司董事会议事规则 | 2025-11-12 | Chinese | ||
| 39585368 | 广州必贝特医药股份有限公司董事及高级管理人员离职管理制度 | 2025-11-12 | Chinese | ||
| 39585363 | 中信证券股份有限公司关于广州必贝特医药股份有限公司使用部分闲置募集资金进行现金管理的核查意见 | 2025-11-12 | Chinese | ||
| 39585355 | 中信证券股份有限公司关于广州必贝特医药股份有限公司调整募集资金投资项目拟投入募集资金金额的核查意见 | 2025-11-12 | Chinese | ||
| 39585347 | 中信证券股份有限公司关于广州必贝特医药股份有限公司使用自有资金支付募投项目所需资金并以募集资金等额置换的核查意见 | 2025-11-12 | Chinese | ||
| 39585339 | 必贝特首次公开发行股票科创板上市公告书 | 2025-10-26 | Chinese | ||
| 39585260 | 必贝特公司章程 | 2025-10-26 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BEBETTER MED INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58625/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58625 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58625 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58625 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58625}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BEBETTER MED INC. (id: 58625)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.